Parexel International (ma) Corporation
Location
Massachusetts
Founded
1983-02-28
Website
Risk Signals
451 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Parexel International (ma) Corporation
Live alerts from global media, monitored by Business Radar
2024-12-02 (usaherald.com)
Former Parexel Employee Sues Over COVID19 Vaccine Mandate USA Herald
Kelly Carijen, a former high-earning employee of clinical research firm Parexel International, has filed a lawsuit in Massachusetts state court alleging that the company's COVID-19 vaccine mandate violated her rights to informed consent and breached her employment contract. The complaint, filed Friday in Middlesex County Superior Court, seeks at least $1 million in damages from A former Parexel employee is suing over the company’s COVID-19 vaccine mandate
Read more
2021-12-13 (informa.com)
Parexel Exec Says Non-COVID-19 Drug Discovery Back With A Bang
Clinical trial initiations in cell and gene therapies and immuno-oncology are seeing a spike as the COVID-19 experience has shown the benefits of beginning research early, Parexel’s executive vice president says.
Read more
2021-11-25 (parexel.com)
Newsroom | Parexel International Corporation
04-10-2021 · Parexel in the News October 14, 2021. Sponsored: Uncovering Long-Term COVID in Drug Development. October 13, 2021. Industry Game Changer: RWE Impacts on Drug Development. October 8, 2021.
Read more
2020-05-20 (globenewswire.com)
Parexel Launches New #KeepingPatientsFirst Integrated Research Platform Powered by Microsoft Azure Providing Rapid Access to Critical New COVID-19 Data
Parexel’s leading Real-World Evidence expertise combined with Microsoft’s innovative cloud technology will support physicians and researchers in better understanding and adjusting treatment in real-time
Read more
2020-05-18 (contractpharma.com)
COVID-19’s Long-Term Impact On Drug Development: The New Pragmatism
The rise of new tools and approaches, an increase in regulatory responsibility, and the need for speed.
Read more
2020-04-16 (fiercebiotech.com)
CRO industry 'disrupted,' with Parexel, IQVIA 'weakly positioned' to take pandemic hit: Moody's
A report out by financial consultancy Moody’s has found that the COVID-19 will hit the CRO industry but hopes impact will be limited. | A report out by financial consultancy Moody’s has found that COVID-19 will hit the CRO industry but hopes the impact will be limited.
Read more
2020-03-30 (forbes.com)
Big Data In The Time Of Coronavirus (COVID-19)
How Big Data can help our understanding of Coronavirus (COVID-19)
Read more
(indiacsr.in)
CSR Interview with Annappa Kamath, Senior Solutions Consultant Director, Parexel
In this Interview with India CSR, Annappa Kamath, Senior Solutions Consultant Director, Parexel talks about the company’s key CSR focus areas, its
Read more
(biospace.com)
Clinical Trials Market Size to Increase USD 153.59 Billion by 2033
According to Nova One Advisor, the global clinical trials market size was estimated at USD 81.90 billion in 2023 and it is projected to increase USD 153.59 billion by 2033 with a CAGR of 6.49% from 2024 to 2033.
Read more